This inventor holds 1 USPTO granted patent. Top assignee: Kosan Biosciences Incorporated. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: J Michael Sherrill: Innovator in Cancer Treatment
Introduction
J Michael Sherrill is a notable inventor based in Danville, CA (US). He has made significant contributions to the field of cancer treatment, particularly in the area of multiple myeloma. His innovative approach has the potential to improve patient outcomes and advance medical science.
Latest Patents
J Michael Sherrill holds a patent for a method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either. This patent outlines a method for treating multiple myeloma in a subject by administering 17-allylamino-17-demethoxy-geldanamycin or 17-amino geldanamycin, or a prodrug of either 17-AAG or 17-AG, to the subject. He has 1 patent to his name, showcasing his innovative contributions to medical research.
Career Highlights
Sherrill is associated with Kosan Biosciences Incorporated, a company focused on developing innovative therapies for cancer treatment. His work at Kosan has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to cancer research.
Collaborations
Some of his notable coworkers include Alison Hannah and Robert G Johnson, Jr. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in cancer treatment methodologies.
Conclusion
J Michael Sherrill's work in developing methods for treating multiple myeloma exemplifies the impact of innovation in the medical field. His contributions are paving the way for future advancements in cancer therapies.